TRUST THE SCIENCE

Of note, SARS-CoV-2 T-cell response seems to be mainly mediated by CD4 T cells. This immunity appears also to be long-lasting e.g. SARS-1 has remained for 18 years. Of 23 patients who had SARS-1 in 2003, researchers found all 23 retained memory T cells induced by the parental SARS-1 pathogen in their systems after 17 to 18 years. Moreover, when they looked at convalescent SARS-CoV-2 patients (n=36), they uncovered that the 36 had also produced similar memory T cells

POST INFECTION IMMUNITY IS ROBUST LASTS FOR DECADES AND UBIQUITOUS .

CROSS INFECTION IMMUNITY IS LIKEWISE .

AND HAVING HAD THE COMMON COLD PROTECTS YOU . PASS IT ON

https://trialsitenews.com/what-about-re-infections-with-the-covid-virus-is-it-common-and-will-we-have-cellular-immunity/

In closing, we also argue that if you are re-infected, it is most likely not with the initial parental strain you were infected with and most likely with a variant. Moreover, had you developed natural exposure immunity, this is usually a robust and durable safeguard against variants. There are many questions at this time as to the ability of the very narrow ‘spike-specific’ immunity (spike epitopes) conferred by the mRNA and adenovirus vector delivery platforms. It is possible and highly probable that variants could blow past the existing vaccines, and we are seeing this today whereby doctors report that 60% of the new COVID infections already have had both vaccination shots. This phenomenon post-vaccination warrants urgent focus by authorities and study.